Podcast: Play in new window | Download
Summary
On episode 106 of 40+ Fitness, Coach Allan sits down with Dr. Mache Seibel, one of America’s leading experts on women’s wellness and menopause, who served on the Harvard Medical School faculty for 20 years and was honored by the North American Menopause Society for advancing public knowledge of menopause.
Dr. Mache unpacks the widely misunderstood 2002 Women’s Health Initiative study, which tested estrogen combined with a synthetic progestin against a placebo group of younger, healthier women, and explains how the press turned a flawed comparison into a broad fear of estrogen itself.
The conversation covers what later research actually shows about estrogen’s effect on breast cancer, heart disease, and dementia risk, and introduces his concept of the “estrogen window,” the safest and most effective time to begin hormone therapy after the onset of menopause.
Links
- https://estrogenwindowbook.com/purchase
- https://drmache.com
- https://menopausequiz.com
- https://menopausebreakthrough.com
- https://askdrmache.com
Key Takeaways
- The 2002 Women’s Health Initiative study is widely misread. It actually tested estrogen combined with a synthetic progestin (Prempro), not estrogen alone, and compared women ages 60 to 79, many of whom smoked or had diabetes or high blood pressure, against a placebo group of healthier women ages 50 to 59, an unbalanced comparison the press flattened into “estrogen causes cancer.”
- Estrogen alone, taken at the right time, appears to lower risk rather than raise it. Later studies comparing women of the same age found estrogen-only users had roughly a 23 percent lower risk of breast cancer, about a 25 percent lower risk of heart disease, and a lower risk of dementia.
- Untreated early menopause raises dementia risk substantially. Women who go into early menopause and don’t take estrogen face about a 70 percent increased risk of dementia.
- Whether estrogen can be taken alone depends on the uterus. Women without a uterus can safely take estrogen alone; women who still have one need estrogen paired with progesterone, since estrogen alone raises the risk of uterine cancer.
- Timing, not just whether you take hormones, is the real variable. The “estrogen window” is the safe period beginning at the onset of menopause, and different organs, the brain, breast, bone, and bladder, each keep that window open for a different length of time.
- Menopause is defined by transition, not a fixed age. The average age of onset is 51, but 5 to 10 percent of women reach menopause before 45, 1 in 100 before 40, 1 in 1,000 before 30, and symptoms can start up to a decade before periods stop.
- Combined estrogen-progestin therapy still has real benefits for women with a uterus. It brings a modest reduction in osteoporosis risk, a lower dementia risk, and a slightly lower heart disease risk, with breast cancer risk essentially unchanged, while relieving menopause symptoms.
- Osteoporosis is a bigger threat than most women realize. For a healthy 50-year-old woman, the risk of eventually dying from a hip fracture is roughly the same as her risk of dying from breast cancer.
- Flawed headlines follow a familiar pattern. Allan draws a parallel to the “red meat causes cancer” headlines, where a study about processed red meat got reported as if it applied to red meat generally, the same kind of oversimplification that drove fear of estrogen after 2002.
“It’s very important to realize that the data initially got it wrong.”
Dr. Mache Seibel
Another Episode You May Enjoy
Episode 123 – The Menopause Solution with Dr. Stephanie Faubion